STRATA Non Current Assets Total vs Current Deferred Revenue Analysis
| SSKN Stock | USD 3.05 0.05 1.61% |
STRATA Skin financial indicator trend analysis is much more than just breaking down STRATA Skin Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether STRATA Skin Sciences is a good investment. Please check the relationship between STRATA Skin Non Current Assets Total and its Current Deferred Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
Non Current Assets Total vs Current Deferred Revenue
Non Current Assets Total vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of STRATA Skin Sciences Non Current Assets Total account and Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between STRATA Skin's Non Current Assets Total and Current Deferred Revenue is 0.5. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of STRATA Skin Sciences, assuming nothing else is changed. The correlation between historical values of STRATA Skin's Non Current Assets Total and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of STRATA Skin Sciences are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Non Current Assets Total i.e., STRATA Skin's Non Current Assets Total and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.5 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Most indicators from STRATA Skin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into STRATA Skin Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. As of the 24th of November 2024, Selling General Administrative is likely to drop to about 8.9 M. In addition to that, Tax Provision is likely to grow to about (87.4 K)
STRATA Skin fundamental ratios Correlations
Click cells to compare fundamentals
STRATA Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
STRATA Skin fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 27.2M | 3.4M | 3.4M | 3.5M | 3.5M | 4.0M | |
| Other Current Liab | 4.5M | 1.6M | 2.4M | 2.5M | 1.7M | 1.4M | |
| Accounts Payable | 1.8M | 2.8M | 2.8M | 3.4M | 3.3M | 2.5M | |
| Other Assets | 428K | 347K | 1.3M | 216K | 248.4K | 301.5K | |
| Property Plant Equipment | 5.3M | 5.4M | 6.5M | 7.5M | 8.6M | 4.7M | |
| Other Liab | 499K | 178K | 288K | 666K | 765.9K | 1.1M | |
| Net Tangible Assets | 12.7M | 11.9M | 10.7M | 6.5M | 5.9M | 6.7M | |
| Retained Earnings Total Equity | (229.4M) | (210.8M) | (214.6M) | (219.0M) | (197.1M) | (206.9M) | |
| Capital Surpluse | 251.6M | 242.0M | 243.2M | 244.8M | 281.6M | 235.9M |
Pair Trading with STRATA Skin
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STRATA Skin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STRATA Skin will appreciate offsetting losses from the drop in the long position's value.Moving against STRATA Stock
| 0.63 | CVS | CVS Health Corp Aggressive Push | PairCorr |
| 0.36 | PHG | Koninklijke Philips | PairCorr |
| 0.33 | FIGS | Figs Inc | PairCorr |
The ability to find closely correlated positions to STRATA Skin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STRATA Skin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STRATA Skin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STRATA Skin Sciences to buy it.
The correlation of STRATA Skin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STRATA Skin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STRATA Skin Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STRATA Skin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STRATA Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.60) | Revenue Per Share 9.347 | Quarterly Revenue Growth 0.022 | Return On Assets (0.07) | Return On Equity (0.63) |
The market value of STRATA Skin Sciences is measured differently than its book value, which is the value of STRATA that is recorded on the company's balance sheet. Investors also form their own opinion of STRATA Skin's value that differs from its market value or its book value, called intrinsic value, which is STRATA Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STRATA Skin's market value can be influenced by many factors that don't directly affect STRATA Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STRATA Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.